- Research article
- Open Access
Transcriptional profiling of gastric epithelial cells infected with wild type or arginase-deficient Helicobacter pylori
© Kim et al.; licensee BioMed Central Ltd. 2012
- Received: 28 October 2011
- Accepted: 18 July 2012
- Published: 13 August 2012
Helicobacter pylori causes acute and chronic gastric inflammation induced by proinflammatory cytokines and chemokines secreted by cells of the gastric mucosa, including gastric epithelial cells. Previous studies have demonstrated that the bacterial arginase, RocF, is involved in inhibiting T cell proliferation and CD3ζ expression, suggesting that arginase could be involved in a more general dampening of the immune response, perhaps by down-regulation of certain pro-inflammatory mediators.
Global transcriptome analysis was performed on AGS gastric epithelial cells infected for 16 hours with a wild type Helicobacter pylori strain 26695, an arginase mutant (rocF-) or a rocF + complemented strain. H. pylori infection triggered altered host gene expression in genes involved in cell movement, death/growth/proliferation, and cellular function and maintenance. While the wild type strain stimulates host inflammatory pathways, the rocF- mutant induced significantly more expression of IL-8. The results of the microarray were verified using real-time PCR, and the differential levels of protein expression were confirmed by ELISA and Bioplex analysis. MIP-1B was also significantly secreted by AGS cells after H. pylori rocF- mutant infection, as determined by Bioplex. Even though not explored in this manuscript, the impact that the results presented here may have on the development of gastritis, warrant further research to understand the underlying mechanisms of the relationship between H. pylori RocF and IL-8 induction.
We conclude that H. pylori arginase modulates multiple host signaling and metabolic pathways of infected gastric epithelial cells. Arginase may play a critical role in anti-inflammatory host responses that could contribute to the ability of H. pylori to establish chronic infections.
- Helicobacter pylori
Helicobacter pylori (H. pylori) causes a spectrum of gastric diseases ranging from mild to severe gastritis and peptic ulcers to gastric cancer . During early stages of infection, H. pylori adheres to the gastric epithelial cells in the gastric pit, leading to induction of chemokines and cytokines. These proinflammatory mediators induce the infiltration of neutrophils and lymphocytes. Despite this immune response, the infection is not cleared  and patients can remain chronically-infected for decades if not treated. This chronicity suggests the bacterium has evolved strategies to persist in the gastric mucosa despite strong immune responses, indicating that H. pylori, in addition to inducing factors to promote inflammation, may also have factors to dampen the host immune responses.
Several H. pylori factors have been associated with virulence including the vacuolating cytotoxin (VacA), the product of the cytotoxin-associated gene (CagA) and the H. pylori urease [3–9]. However, the mechanisms of pathogenesis caused by other H. pylori factors are only beginning to be understood.
H. pylori arginase [EC 3.5.31, RocF] hydrolyzes arginine to ornithine and urea, the latter of which may serve as an endogenous substrate for the powerful H. pylori urease enzyme, to generate carbon dioxide and ammonia. The H. pylori RocF is associated with the inner cell membrane and uses cobalt as cofactor, as opposed to mammalian arginases which use manganese [10–12]. Interestingly, arginase activity has an acidic pH optimum and increases the resistance of H. pylori to acid in an arginine-dependent fashion . Moreover, since the rocF- mutant is unable to hydrolyze and consume arginine [13, 14], extracellular arginine levels are readily available for macrophages to produce nitric oxide (NO) to kill the bacteria .
Both in a tissue culture system and from peripheral blood from human volunteers, it was shown that, in contrast with wild type H. pylori, the rocF- mutant promotes T cell proliferation and expression of the important T cell surface signaling molecule, CD3ζ . Thus, arginase is involved in dampening the innate (acid, NO) and adaptive (T cell) immune responses, but the specific mechanisms are not entirely understood. H. pylori arginase in gastric epithelial cell response is unknown. We therefore sought to determine the impact of H. pylori rocF- on epithelial cell transcription and cytokine/chemokine profiles using Illumina gene chip analysis, real-time PCR, ELISA and Bioplex analysis.
Differential gene expression profile between H. pylori 26695 wild type and rocF- mutant strains
Ten most up- and 10 most down-regulated genes in AGS cells in response to the infection with the different strains of H. pylori
The rocF- H. pylori mutant induces more IL-8 in gastric epithelial cells than wild type H. pylori
While it is well-known that H. pylori induces inflammation, this inflammatory response is insufficient to clear the organism from the gastric mucosa and the organism overcomes the immune response to cause chronic infections that can last for decades in untreated patients. Paradoxically, H. pylori may have both pro-inflammatory as well as anti-inflammatory mechanisms. These opposing forces must operate in such a fashion as to achieve a delicate balance that involves complex interactions between bacterial virulence factors and host innate and adaptive immune system factors.
How does arginase in wild type H. pylori act as an anti-inflammatory mediator? While the underlying mechanisms are still not well understood, the depletion of arginine by this enzyme from the extracellular environment may be one factor that triggers altered gene expression in the gastric epithelial cell. Precedence for this idea comes from prior work showing that arginine depletion leads to altered T cell receptor zeta chain expression (CD3ζ) . Another possibility is that the products of arginine hydrolysis, namely, ornithine and urea, could also be playing a role in altering transcriptional responses by the gastric epithelial cells. A third possibility is that the arginase mutant, through disruption of the bacterial metabolic balance of arginine, ornithine, or urea levels, could have altered gene transcriptional profiles leading to modified expression of other bacterial virulence factors that interplay with the host immune system.
A fourth possibility is that the increase in IL-8 production induced by the H. pylori rocF- mutant is through altered spermine produced by the AGS cells. Previous reports have shown that H. pylori infection induces ornithine decarboxylase (ODC) in macrophages [15, 18]. ODC degrades L-ornithine into putrescine and this is later converted into spermidine and finally spermine. Although we did not find differences in the level of mRNA for the spermine synthase (SMS), we did find that ornithine decarboxylase (ODC) and spermidine synthase mRNA (SRM), two key enzymes in the production of spermine, were 20% and 41%, respectively, reduced in the rocF-mutant-infected AGS cells (data not shown). It has also been shown that spermine can reduce the inflammatory response by post-transcriptional inhibition of the production of pro-inflammatory cytokines, including TNFα, IL6, MIP-1α, and MIP-1β , and even though IL-8 was not included in this study, it is possible that it is regulated by spermine as well. Thus, in the interaction of wild type H. pylori with AGS cells, spermine levels may be elevated in the AGS cells, leading to a dampening of the chemokine/cytokine pro-inflammatory response. These possibilities await further in depth analyses.
We performed pair-wise comparison of transcriptome on the human adenocarcinoma gastric cell line AGS after infection with 26695 wild type, its isogenic rocF- knockout mutant, and a rocF- complemented (rocF+) H. pylori strain, with uninfected AGS cells as a control. The first observation with the microarray analysis was an overall increase in the number of genes that participate in several signaling pathways previously investigated with H. pylori infection, notably with NFKB and AP-1 activation and mitogen-activated protein kinase (especially ERKs, JNKs, SAPKs) , along with JUN-mediated signaling. From this activation cascade, the induction of IL-8 marked the greatest difference between the rocF- mutant H. pylori versus either the WT or the rocF + complemented strain. Our results show a significant increase of mRNA and protein levels of IL-8 in AGS cells infected with the rocF- mutant strain, suggesting that WT bacteria may be able to control the inflammatory infiltration of immune cells by controlling the production of IL-8, which is a potent chemotactic factor for inflammatory cells, especially neutrophils [21–24].
While many H. pylori factors have been suggested to stimulate IL-8 expression, including peptidoglycan, LPS, CagA, VacA, PicB, IceA, urease (and even ammonia) [25–28], less is known about bacterial factors involved in suppression of cytokine production, especially in epithelial cells. Mechanisms for immune evasion by H. pylori have been demonstrated, including the presence of a less potent LPS and cholesterol glycosylation ; however, fewer studies dealt with reduced host cytokine production as an immune suppressive mechanism, including effects on IL-12 [30–32]. While an increased amount of cytokines can result in histologically more intense gastritis , the limitation of this cytokine induction could be an advantage to the bacteria so that it can stay under the radar of the immune system. However, due to the complexity of the H. pylori-gastric cell interaction, and the complexity of the lesions induced by the infection, it is expected that multiple pathways are activated and the balance of those pathways may determine the presence or the evolution of the gastric lesions.
Efforts to determine the effect of the infection with H. pylori rocF- strains in the cellular infiltration of the gastric mucosa are currently underway. To the best of our knowledge, there is only one published work trying to measure the levels of H. pylori arginase in gastric biopsies of patients with gastritis and its correlation with disease . That work showed that there is a lot of variability on the levels of H. pylori arginase in biopsies but the authors were not able to establish a correlation with the degree of gastritis. The reason for the increased number of genes modulated by the rocF- H. pylori, when compared to the WT and the rocF+ bacteria, is not known; however, our results, rather than suggesting the existence of H. pylori arginase mutants in human gastric lesions, highlights the importance that this enzyme may have in the interaction of the bacteria with cells in the human gastric mucosa, and through them, with the immune system. Taken together our results suggest that H. pylori arginase, by modulating the production of IL-8 may play a significant role in the survival of H. pylori in the gastric environment. By preventing an over-zealous immune response, H. pylori can achieve its chronicity through the production of arginase and probably other bacterial factors that contribute to the overall global success of this important and highly-adapted gastric human pathogen.
Our results highlight the importance of H. pylori arginase in the modulation of inflammatory responses. Since IL-8 is pivotal for the infiltration of inflammatory cells into the gastric mucosa, H. pylori arginase may be involved in reducing the tissue damage associated with the evolution of the gastric lesions through the modulation of multiple pathways on the gastric epithelial cells.
Bacterial growth conditions
H. pylori 26695 strains (wild type [WT], rocF- mutant, and the rocF- mutant chromosomally-complemented with wild type 26695 rocF- (rocF-26695-MLB0004, hereafter referred to as rocF+) were described previously . All strains were passaged every 2–3 days on Campylobacter blood agar (CBA) plates at 37°C with 85% N2, 5% O2, and 10% CO2. Prior to coculture experiments, H. pylori cells were grown in Ham’s F-12 with heat-inactivated 1% (v/v) fetal bovine serum (FBS) . H. pylori growth was monitored by ATP level using Cell Titer-Glo® cell viability assay kit (Promega, NY, USA), as validated previously  and by plating for colony forming units. Comparable number of viable bacteria was assured in each experiment.
Tissue culture and co-culture
AGS gastric epithelial cells (ATCC CRL-1739, Rockville, MD) were maintained in F-12 with heat-inactivated 10% FBS at 37°C in an atmosphere of 5% CO2. For the experiments, 1 x 106 AGS cells were seeded into 6-well plates containing 2 ml fresh F-12 supplemented with 3% heat-inactivated FBS and cultured for 8 hours. The media was replaced with 2 ml fresh F-12 containing 3% heat-inactivated FBS before inoculation of the different H. pylori at a multiplicity of infection (MOI) of 20. The infected cells were cultured for additional 16 h after which the media was collected and stored for ELISA and BioPlex analyses and the RNA extracted for microarray and real-time PCR studies.
RNA extraction and microarray
To extract the RNA from the AGS cells, coculture supernatants were removed by aspiration and 1 ml of TRIZOL (Invitrogen, Carlsbad, CA) was added immediately to each well. RNA was extracted as recommended by the manufacturer and was stored at −80°C until further use. RNA was dissolved in DNase/RNase-free water, quantified by NanoDrop (Fisher Scientific) and set at a concentration of ~1.0 μg/μl. The quality of the RNA was confirmed by Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Each experiment was repeated four times. Two hundred ng of RNA were used to make biotinylated cRNA using the Illumina TotalPrep RNA Amplification Kit (Ambion, Austin, TX), and hybridized to the Illumina chips for 14 hours at 58°C. After washing and staining, the arrays were scanned with the BeadArray Reader (Illumina Inc.) and analyzed with the GenomeStudio software (Illumina).
Microarray data analysis
After subtracting the background, the samples were normalized assuming a similar distribution of transcript abundance in all the samples . The net expression level was obtained by subtracting the intensity obtained on each treatment (including non-treated cells) from the intensity at 0 h (prior to seeding the cells into the plate). Then, the gene levels on the infected cells were compared against the levels on the non-infected cells setting the p value for the difference at <0.05. Scatter plots comparing the non-infected cells against each one of the other treatments (AGS + WT, AGS + rocF-, AGS + rocF+) were used to select only those genes with > 3 fold difference (up or down-regulated) as compared with the non-infected cells, and p values less than 0.05 (p < 0.05). In addition, the Log10 of the ratio between the normalized intensity in the infected cells and the normalized intensity in the non-infected cells was determined and used to generate heat maps.
Quantitative real-time PCR
For real-time PCR (qPCR), total RNA extracts were DNase treated and reverse-transcribed with SuperScriptase III (Invitrogen) with random hexamers. TaqMan pre-designed arrays were used to check the levels of mRNA expression of IL-8, using cyclophilin A as housekeeping gene, and following the vendor’s recommendations (Applied Biosystems, Foster City, CA). The 5 μl reaction was subjected to two minutes at 50°C, 10 minutes at 95°C and finally 40 cycles at 95°C for 15 seconds and 60°C for one minute in a 7900HT real-time PCR machine (Applied Biosystems). The delta Ct’s (ΔCt and ΔΔCt) and fold induction of IL-8 were determined using an internal control as calibrator.
BioPlex and enzyme-linked immunosorbent essay (ELISA)
Culture supernatants were collected at indicated time points and clarified of bacteria and host cells by centrifugation (3,000 x g for 5 min and then 16,000 x g for 10 min, 4°C). Manufacturer’s manuals were followed for BioPlex (Bio-Rad, Inc) and human IL-8 ELISA assay (BD OptEIATM, BD Bioscience). For Bio-Plex analysis, 2 μl of anti-cytokine conjugated beads were added to each well, followed by diluted culture supernatants. After 30 min incubation, samples were washed three times with Bio-Plex wash buffer, and then 25 μl of detection antibody solution was added and incubated for another 30 min. Streptavidin-phycoerythrin (1X; 50 μl) was added to each well and then washed. For hIL-8 ELISA, duplicate measurements were done for four separate experiments. Samples were read at 450 nm on an ELISA reader (Bio-Rad), of which lowest detection limit was 0.8 pg/ml (BD OptEIATM, BD Bioscience).
Functional analysis and network generation
Online computational tools of Metacore (Thomson Reuters, Philadelphia, PA) were used to identify annotated networks of interacting genes, pathways and associated biological functions among genes profiled from the microarray analysis, using more than 700 canonical maps and pathways which are continuously being updated (http://www.genego.com). The networks generated were ranked and built according to G-scores and p values.
All data in each experiment of ELISA and real time PCR are presented as mean ± SEM of three or four different experiments. To check for any difference between the several treatments we did a one-way ANOVA analysis. To determine differences between specific treatments we did a two-tailed unpaired t-test.
This work was supported in part by a grant of the Translational Research Initiative of the Louisiana State University Health Sciences Center and by the Louisiana Cancer Research Consortium (LCRC) and COBRE Grant number 149740220B (to JZ) and Public Health Service Grant RO1 CA101931 (to DJM from the National Institutes of Health).
- Blaser MJ: Helicobacter pylori and gastric diseases. BMJ. 1998, 316: 1507-1510. 10.1136/bmj.316.7143.1507.PubMedPubMed CentralView ArticleGoogle Scholar
- Day AS, Jones NL, Policova Z, Jennings HA, Yau EK, Shannon P, et al: Characterization of virulence factors of mouse-adapted Helicobacter pylori strain SS1 and effects on gastric hydrophobicity. Dig Dis Sci. 2001, 46: 1943-1951. 10.1023/A:1010691216207.PubMedView ArticleGoogle Scholar
- Backert S, Ziska E, Brinkmann V, Zimny-Arndt U, Fauconnier A, Jungblut PR, et al: Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol. 2000, 2: 155-164. 10.1046/j.1462-5822.2000.00043.x.PubMedView ArticleGoogle Scholar
- Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R: Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science. 2003, 301: 1099-1102. 10.1126/science.1086871.PubMedView ArticleGoogle Scholar
- Mobley HL, Island MD, Hausinger RP: Molecular biology of microbial ureases. Microbiol Rev. 1995, 59: 451-480.PubMedPubMed CentralGoogle Scholar
- Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R: Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 2000, 287: 1497-1500. 10.1126/science.287.5457.1497.PubMedView ArticleGoogle Scholar
- Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A: c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol. 2002, 43: 971-980. 10.1046/j.1365-2958.2002.02781.x.PubMedView ArticleGoogle Scholar
- Szabo I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford JL, et al: Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J. 1999, 18: 5517-5527. 10.1093/emboj/18.20.5517.PubMedPubMed CentralView ArticleGoogle Scholar
- Tombola F, Morbiato L, Del GG, Rappuoli R, Zoratti M, Papini E: The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J Clin Invest. 2001, 108: 929-937.PubMedPubMed CentralView ArticleGoogle Scholar
- Carvajal N, Torres C, Uribe E, Salas M: Interaction of arginase with metal ions: studies of the enzyme from human liver and comparison with other arginases. Comp Biochem Physiol B Biochem Mol Biol. 1995, 112: 153-159. 10.1016/0305-0491(95)00027-6.PubMedView ArticleGoogle Scholar
- McGee DJ, Zabaleta J, Viator RJ, Testerman TL, Ochoa AC, Mendz GL: Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily. Eur J Biochem. 2004, 271: 1952-1962. 10.1111/j.1432-1033.2004.04105.x.PubMedView ArticleGoogle Scholar
- Mendz GL, Holmes EM, Ferrero RL: In situ characterization of Helicobacter pylori arginase. Biochim Biophys Acta. 1998, 1388: 465-477. 10.1016/S0167-4838(98)00207-6.PubMedView ArticleGoogle Scholar
- Langford ML, Zabaleta J, Ochoa AC, Testerman TL, McGee DJ: In vitro and in vivo complementation of the Helicobacter pylori arginase mutant using an intergenic chromosomal site. Helicobacter. 2006, 11: 477-493. 10.1111/j.1523-5378.2006.00441.x.PubMedPubMed CentralView ArticleGoogle Scholar
- Weeks DL, Eskandari S, Scott DR, Sachs G: A H + −gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science. 2000, 287: 482-485. 10.1126/science.287.5452.482.PubMedView ArticleGoogle Scholar
- Gobert AP, McGee DJ, Akhtar M, Mendz GL, Newton JC, Cheng Y, et al: Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA. 2001, 98: 13844-13849. 10.1073/pnas.241443798.PubMedPubMed CentralView ArticleGoogle Scholar
- Zabaleta J, McGee DJ, Zea AH, Hernandez CP, Rodriguez PC, Sierra RA, et al: Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J Immunol. 2004, 173: 586-593.PubMedView ArticleGoogle Scholar
- Ding SZ, Torok AM, Smith MF, Goldberg JB: Toll-like receptor 2-mediated gene expression in epithelial cells during Helicobacter pylori infection. Helicobacter. 2005, 10: 193-204. 10.1111/j.1523-5378.2005.00311.x.PubMedView ArticleGoogle Scholar
- Bussiere FI, Chaturvedi R, Cheng Y, Gobert AP, Asim M, Blumberg DR, et al: Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J Biol Chem. 2005, 280: 2409-2412.PubMedView ArticleGoogle Scholar
- Zhang M, Caragine T, Wang H, Cohen PS, Botchkina G, Soda K, et al: Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J Exp Med. 1997, 185: 1759-1768. 10.1084/jem.185.10.1759.PubMedPubMed CentralView ArticleGoogle Scholar
- Seo JH, Lim JW, Kim H, Kim KH: Helicobacter pylori in a Korean isolate activates mitogen-activated protein kinases, AP-1, and NF-kappaB and induces chemokine expression in gastric epithelial AGS cells. Lab Invest. 2004, 84: 49-62.PubMedView ArticleGoogle Scholar
- Kunkel SL, Standiford T, Kasahara K, Strieter RM: Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res. 1991, 17: 17-23. 10.3109/01902149109063278.PubMedView ArticleGoogle Scholar
- Matsushima K, Baldwin ET, Mukaida N: Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem Immunol. 1992, 51: 236-265.PubMedGoogle Scholar
- Papoff P, Fiorucci P, Ottaviano C, Bucci G: Interleukin-8: a potent neutrophil chemotactic factor. Arch Dis Child Fetal Neonatal Ed. 1995, 73: F54-PubMedPubMed CentralView ArticleGoogle Scholar
- Roebuck KA: Regulation of interleukin-8 gene expression. J Interferon Cytokine Res. 1999, 19: 429-438. 10.1089/107999099313866.PubMedView ArticleGoogle Scholar
- Sharma SA, Tummuru MK, Miller GG, Blaser MJ: Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun. 1995, 63: 1681-1687.PubMedPubMed CentralGoogle Scholar
- Straubinger RK, Greiter A, McDonough SP, Gerold A, Scanziani E, Soldati S, et al: Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect Immun. 2003, 71: 2693-2703. 10.1128/IAI.71.5.2693-2703.2003.PubMedPubMed CentralView ArticleGoogle Scholar
- Sun J, Aoki K, Zheng JX, Su BZ, Ouyang XH, Misumi J: Effect of NaCl and Helicobacter pylori vacuolating cytotoxin on cytokine expression and viability. World J Gastroenterol. 2006, 12: 2174-2180.PubMedPubMed CentralGoogle Scholar
- Tummuru MK, Sharma SA, Blaser MJ: Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol. 1995, 18: 867-876. 10.1111/j.1365-2958.1995.18050867.x.PubMedView ArticleGoogle Scholar
- Wunder C, Churin Y, Winau F, Warnecke D, Vieth M, Lindner B, et al: Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med. 2006, 12: 1030-1038. 10.1038/nm1480.PubMedView ArticleGoogle Scholar
- Gebert B, Fischer W, Haas R: The Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities. Rev Physiol Biochem Pharmacol. 2004, 152: 205-220.PubMedGoogle Scholar
- Kao JY, Rathinavelu S, Eaton KA, Bai L, Zavros Y, Takami M, et al: Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defense. Am J Physiol Gastrointest Liver Physiol. 2006, 291: G73-G81. 10.1152/ajpgi.00139.2005.PubMedView ArticleGoogle Scholar
- Sewald X, Gebert-Vogl B, Prassl S, Barwig I, Weiss E, Fabbri M, et al: Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe. 2008, 3: 20-29. 10.1016/j.chom.2007.11.003.PubMedView ArticleGoogle Scholar
- Shimoyama T, Fukuda S, Liu Q, Nakaji S, Munakata A, Sugawara K: Ecabet sodium inhibits the ability of Helicobacter pylori to induce neutrophil production of reactive oxygen species and interleukin-8. J Gastroenterol. 2001, 36: 153-157. 10.1007/s005350170122.PubMedView ArticleGoogle Scholar
- Hovey JG, Watson EL, Langford ML, Hildebrandt E, Bathala S, Bolland JR, et al: Genetic microheterogeneity and phenotypic variation of Helicobacter pylori arginase in clinical isolates. BMC Microbiol. 2007, 7: 26-10.1186/1471-2180-7-26.PubMedPubMed CentralView ArticleGoogle Scholar
- Testerman TL, McGee DJ, Mobley HL: Helicobacter pylori growth and urease detection in the chemically defined medium Ham's F-12 nutrient mixture. J Clin Microbiol. 2001, 39: 3842-3850. 10.1128/JCM.39.11.3842-3850.2001.PubMedPubMed CentralView ArticleGoogle Scholar
- Testerman TL, Conn PB, Mobley HL, McGee DJ: Nutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media. J Clin Microbiol. 2006, 44: 1650-1658. 10.1128/JCM.44.5.1650-1658.2006.PubMedPubMed CentralView ArticleGoogle Scholar
- Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielser HB, et al: A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol. 2002, 3: research0048.1-research0048.16-PubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.